लोड हो रहा है...

Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience

BACKGROUND: Most biologic therapies for psoriasis are delivered via subcutaneous injection. Ixekizumab, an anti-interleukin 17A monoclonal antibody approved for patients with moderate-to-severe plaque psoriasis, is delivered subcutaneously via prefilled syringe or autoinjector. Here we report the re...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Med Devices (Auckl)
मुख्य लेखकों: Callis Duffin, Kristina, Bukhalo, Michael, Bobonich, Margaret A, Shrom, David, Zhao, Fangyi, Kershner, James R, Gill, Anne, Pangallo, Beth, Shuler, Catherine L, Bagel, Jerry
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2016
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5067052/
https://ncbi.nlm.nih.gov/pubmed/27785115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/MDER.S113752
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!